WO2007070694A3 - Spray-on formulations and methods for dermal delivery of drugs - Google Patents

Spray-on formulations and methods for dermal delivery of drugs Download PDF

Info

Publication number
WO2007070694A3
WO2007070694A3 PCT/US2006/048060 US2006048060W WO2007070694A3 WO 2007070694 A3 WO2007070694 A3 WO 2007070694A3 US 2006048060 W US2006048060 W US 2006048060W WO 2007070694 A3 WO2007070694 A3 WO 2007070694A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
formulation
formulations
drug
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/048060
Other languages
French (fr)
Other versions
WO2007070694A2 (en
Inventor
Jie Zhang
Kevin S Warner
Sanjay Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zars Inc
Original Assignee
Zars Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zars Inc filed Critical Zars Inc
Priority to JP2008545867A priority Critical patent/JP2009519957A/en
Priority to AU2006326033A priority patent/AU2006326033A1/en
Priority to EP06845634A priority patent/EP1959928A2/en
Priority to CA002633466A priority patent/CA2633466A1/en
Publication of WO2007070694A2 publication Critical patent/WO2007070694A2/en
Anticipated expiration legal-status Critical
Publication of WO2007070694A3 publication Critical patent/WO2007070694A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The present invention is drawn to sprayable formulations, methods of drug delivery, and resultant solidified layers for dermal delivery of a drug. The formulation can include a drug, a non-volatile solvent system, a solidifying agent, and a propellant. The formulation can have an initial viscosity suitable to be expelled out of a pressurized or manual pump container and applied onto a skin surface as a layer. When applied to the skin, the formulation can form a solidified layer after at least a portion of the propellant is evaporated.
PCT/US2006/048060 2005-12-14 2006-12-14 Spray-on formulations and methods for dermal delivery of drugs Ceased WO2007070694A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2008545867A JP2009519957A (en) 2005-12-14 2006-12-14 Spray-on formulations and methods for dermal delivery of drugs
AU2006326033A AU2006326033A1 (en) 2005-12-14 2006-12-14 Spray-on formulations and methods for dermal delivery of drugs
EP06845634A EP1959928A2 (en) 2005-12-14 2006-12-14 Spray-on formulations and methods for dermal delivery of drugs
CA002633466A CA2633466A1 (en) 2005-12-14 2006-12-14 Spray-on formulations and methods for dermal delivery of drugs

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75063705P 2005-12-14 2005-12-14
US60/750,637 2005-12-14
US79509106P 2006-04-25 2006-04-25
US60/795,091 2006-04-25

Publications (2)

Publication Number Publication Date
WO2007070694A2 WO2007070694A2 (en) 2007-06-21
WO2007070694A3 true WO2007070694A3 (en) 2008-12-24

Family

ID=38163552

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/048060 Ceased WO2007070694A2 (en) 2005-12-14 2006-12-14 Spray-on formulations and methods for dermal delivery of drugs

Country Status (5)

Country Link
EP (1) EP1959928A2 (en)
JP (1) JP2009519957A (en)
AU (1) AU2006326033A1 (en)
CA (1) CA2633466A1 (en)
WO (1) WO2007070694A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8193233B2 (en) 2009-02-13 2012-06-05 Topica Pharmaceuticals, Inc. Anti-fungal formulation

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100076037A1 (en) * 2006-11-02 2010-03-25 Chiang Lillian W Methods of Treating Neuropathic Pain with Agonists of PPAR-gamma
PL2244737T3 (en) * 2008-01-22 2020-05-18 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
WO2010008600A1 (en) * 2008-07-16 2010-01-21 Dermworx Incorporated Topical drug delivery system
US20100160368A1 (en) 2008-08-18 2010-06-24 Gregory Jefferson J Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
CA2752070C (en) 2009-02-12 2017-11-28 Precision Dermatology, Inc. Foamable benzoyl peroxide compositions for topical administration
GEP20156418B (en) 2009-07-13 2016-01-11 Medicis Pharmaceutical Corp Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
KR101749514B1 (en) * 2010-06-11 2017-06-21 레오 파마 에이/에스 A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
GB2496656B (en) * 2011-11-18 2015-12-09 Lrc Products Film-Forming Formulation
CN104519869A (en) * 2012-07-06 2015-04-15 利奥制药有限公司 A topical composition comprising a film-forming polymer for delivering an active ingredient to skin
CA2966843A1 (en) 2014-11-10 2016-05-19 Achelios Therapeutics, Inc. Sprayable analgesic compositions
CN105169464B (en) * 2015-09-24 2018-05-15 中国人民解放军军事医学科学院放射与辐射医学研究所 A kind of natural honey wound dressing and preparation method and application
CN111067919A (en) * 2019-12-23 2020-04-28 李益谦 Spray analgesic
WO2024145192A1 (en) * 2022-12-28 2024-07-04 Basf Se Topical spray composition and preparation thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
US20050089539A1 (en) * 2003-09-09 2005-04-28 3M Innovative Properties Company Antimicrobial compositions and methods

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
US20050089539A1 (en) * 2003-09-09 2005-04-28 3M Innovative Properties Company Antimicrobial compositions and methods

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8193233B2 (en) 2009-02-13 2012-06-05 Topica Pharmaceuticals, Inc. Anti-fungal formulation
US8193232B2 (en) 2009-02-13 2012-06-05 Topica Pharmaceuticals, Inc. Anti-fungal formulation
US8362059B2 (en) 2009-02-13 2013-01-29 Topica Pharmaceuticals, Inc. Anti-fungal formulation

Also Published As

Publication number Publication date
JP2009519957A (en) 2009-05-21
CA2633466A1 (en) 2007-06-21
EP1959928A2 (en) 2008-08-27
AU2006326033A1 (en) 2007-06-21
WO2007070694A2 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
WO2005120473A3 (en) Dermal peel-forming formulation
WO2007070694A3 (en) Spray-on formulations and methods for dermal delivery of drugs
WO2009017767A3 (en) Compositions and methods for dermally treating neuropathy with minoxidil
WO2007070643A3 (en) Compositions and methods for treating dermatological conditions
WO2007070679A3 (en) Compositions and methods for dermally treating pain
WO2006129161A3 (en) Vitamin formulation
MY161895A (en) Dermal film-forming liquid formulations for drug release to skin
WO2005076697A3 (en) Cosmetic and pharmaceutical foam with solid matter
WO2005115336A3 (en) Sprayable formulations for the treatment of acute inflammatory skin conditions
WO2007047948A3 (en) Intranasal administration of rapid acting insulin
WO2011150144A3 (en) Aqueous formulations for coating microneedle arrays
WO2007095043A3 (en) Pharmaceutical formulations
WO2012066506A3 (en) Method for fabricating a microneedle
WO2007100376A3 (en) Compositions and methods for dermal delivery of drugs
WO2005048952A3 (en) Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
WO2009061607A3 (en) Water-immiscible materials as vehicles for drug delivery
WO2010017821A8 (en) Coated tablets with a remaining degradation surface over the time
WO2007123955A3 (en) Stable hydroalcoholic oral spray formulations and methods
WO2008062429A3 (en) Particles for delivery of active ingredients, process of making and compositions thereof
WO2010081824A3 (en) Active coating of pharmaceutical dosage forms
WO2009032665A3 (en) Porous medical articles for therapeutic agent delivery
WO2008072120A3 (en) Microencapsulated delivery vehicle having an aqueous core
WO2009100441A3 (en) Depot formulations
WO2007133508A8 (en) Water dispersible films for delivery of active agents to the epidermis
WO2010072958A3 (en) Topical pharmaceutical composition containing a water-sensitive active principle

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2008545867

Country of ref document: JP

Ref document number: 2633466

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006326033

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2006845634

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 0812222

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20061222

WWE Wipo information: entry into national phase

Ref document number: 1484/MUMNP/2008

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2006326033

Country of ref document: AU

Date of ref document: 20061214

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 200680051532.1

Country of ref document: CN